Floatz logo

Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor 2/Neu Dendritic Cell Vaccine

Metastatic Solid Tumors Characterized by HER2/Neu Expression

National Cancer Institute (NCI)unclassifiedPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Metastatic Solid Tumors Characterized by HER2/Neu Expression cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor 2/Neu Dendritic Cell Vaccine is also rated in:

lung adenocarcinomaDormant
CC
Indicative ·
47 / 100
View asset →
breast neoplasmDormant
CC
Indicative ·
40 / 100
View asset →
breast cancerDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →